Live Breaking News & Updates on Inflammatory Arthritis

Stay updated with breaking news from Inflammatory arthritis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel Scoring System May Better Identify Patients at Risk for Inflammatory Arthritis

Researchers analyzed numerous biomarkers in patients at risk for inflammatory arthritis to develop measurable scores indicating a patient's vulnerability to disease progression. ....

United Kingdom , Health Assessment Questionnaire , Internal Medicine , Inflammatory Arthritis , Rheumatoid Arthritis ,

What is gout? Here's what you need to know about this painful Inflammatory arthritis

Gout often affects the big toe, but it can also target other joints like the ankles, knees, wrists, and elbows. The symptoms of gout can be sudden and intense, with the following common signs:

....

Uric Acid , Inflammatory Arthritis , Main In Feet , Health And Lifestyle News ,

#VisualAbstract: SGLT2 inhibitors reduce recurrent flares and hospitalizations in patients with gout

In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than those using dipeptidyl peptidase 4 inhibitors (DPP-4is). Those who used SGLT2 inhibitors also presented to the emergency department (ED) less frequently for gout-related visits than those using DPP-4is. Evidence Rating Level: 1 (Excellent) Study Rundown: Gout is a ....

United Kingdom , Health Problems , International Statistical Classification Of Diseases , Minute Medicine Inc , Rating Level , Gout With Sodium , Patients With Type , British Columbia , International Statistical Classification , Related Health Problems , Confidence Interval , Chronic Disease , Inflammatory Arthritis , Sglt2 Inhibitors ,

SGLT2 inhibitors reduce recurrent flares and hospitalizations in patients with gout

1. In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than those using dipeptidyl peptidase 4 inhibitors (DPP-4is). 2. Those who used SGLT2 inhibitors also presented to the emergency department (ED) less frequently for gout-related visits than those using DPP-4is. Evidence Rating Level: 1 (Excellent) Study ....

United Kingdom , International Statistical Classification Of Diseases , Health Problems , Minute Medicine Inc , Rating Level , Gout With Sodium , Patients With Type , British Columbia , International Statistical Classification , Related Health Problems , Confidence Interval , Chronic Disease , Dipeptidyl Peptidase 4 Inhibitors , Inflammatory Arthritis , Sglt 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors ,

ICI therapy linked to unique immune response in arthritis

Immune checkpoint inhibitor (ICI) therapies used to treat cancer come with the risk of adverse autoimmune responses, including arthritis that can persist for years and require joint replacement surgery. ....

Lily Ramsey , Deepaka Rao , Brigham Division Of Rheumatology , Mass General Brigham , Inflammatory Arthritis , Psoriatic Arthritis , Rheumatoid Arthritis ,